Kalpa Mounjarixyl 5 mg GIP and GLP-1 Research Vial for Labs

It is a lyophilised research vial containing 5 mg of the Kalpa branded dual incretin agonist peptide. Mounjarixyl is an internal Kalpa trade name with no published description, so the class is taken from the product subtitle on the line, which states GIP and GLP-1 agonism. The vial is a research material rather than a licensed medicine.

It activates two receptors, GIP and GLP-1, instead of one. GLP-1 activity slows gastric emptying and reduces appetite, while GIP activity adds a second route into the same appetite and glucose control system, which is why trial effects are larger than with a single agonist. The insulin effect remains glucose dependent, so it strengthens when blood glucose is already high.

Population pharmacokinetic work on the licensed analogue gives a mean half-life of 5.4 days, extended by a lipid side chain that increases albumin binding. Those numbers come from the approved product, not from this vial, and they explain weekly dosing as well as the slow fade after treatment ends, when about 14 per cent of body mass returns within a year.

Two millilitres of bacteriostatic water give 2.5 mg per ml, so the 2.5 mg weekly reference amount measures 1 ml on a U-100 syringe; 1 ml of solvent gives 5 mg per ml and halves every volume. Add the water down the vial wall, do not shake, then keep the solution at 2-8 C without freezing. Reconstitution arithmetic like this is laboratory work rather than the licensed pen.

Gastrointestinal effects lead the profile: nausea, diarrhoea, vomiting and constipation, strongest during escalation, which is why the approved ladder moves in four week steps. Injection site reactions are also frequent, and the labelling of the licensed analogue carries a boxed warning for thyroid C cell tumours seen in animal work. Unapproved versions from outside the licensed supply chain have drawn regulator warnings.

No. Neither GIP nor GLP-1 agonists are on the WADA prohibited list, and the class is tracked through the monitoring programme rather than banned. That is a lighter position than growth hormone secretagogues such as ipamorelin, which are prohibited at all times. Athletes should confirm the current list with their federation before using anything.

Yes. The 5 mg vial is listed on this page with international and U.S. domestic shipping options, and the price charged matches the option you select. Orders are dispatched after payment confirmation. The product is sold strictly for laboratory research and is not a licensed medicine in any country.